These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 7468138

  • 1. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ, Linssen GH.
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [Abstract] [Full Text] [Related]

  • 2. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ, Linssen GH.
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [Abstract] [Full Text] [Related]

  • 3. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R, Colby C, El-Etr A, Pifarré R.
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [Abstract] [Full Text] [Related]

  • 5. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA, Lewis M.
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [Abstract] [Full Text] [Related]

  • 6. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA, Pereira SN, Moraes LB, Costa PS, Deboni LM, Figueiredo MS.
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [Abstract] [Full Text] [Related]

  • 7. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y, Imai Y, Seo K, Terada M, Aoki M, Shin'oka T.
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [Abstract] [Full Text] [Related]

  • 8. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 9. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Mar; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 11. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS, Huse WM, Brauer FS, Korpman RA.
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [Abstract] [Full Text] [Related]

  • 12. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L, Reich DL, DePerio M.
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [Abstract] [Full Text] [Related]

  • 13. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 14. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR.
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [Abstract] [Full Text] [Related]

  • 15. [A computerized method for the administration of heparin and protamine during open-heart surgery].
    Isshiki A, Sakaguchi Y, Kubota K, Ikeda T.
    Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734
    [No Abstract] [Full Text] [Related]

  • 16. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU, Wayne CK, Barker J, Strang T.
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [Abstract] [Full Text] [Related]

  • 17. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G, Grünes G.
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [Abstract] [Full Text] [Related]

  • 18. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ, Berzina-Moettus L, Rabinovitch A, Ankeney JL.
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K.
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.